NAS:BEAM (N/A)

Beam Therapeutics Inc $ 26.73 -3.84 (-12.56%)

Volume:
469,596
Avg Vol (1m):
319,565
Market Cap $:
1.38 Bil
Enterprise Value $:
1.16 Bil
P/E (TTM):
0.00
P/B:
5.01
Warning! GuruFocus has detected 1 Severe warning sign with BEAM. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

BEAM News and Headlines - Beam Therapeutics

GuruFocus Articles Total 1
  • 1

Company shares up substantially since early February IPO

Shares of a Cambridge, Massachusetts-based biotechnology company that is taking a different approach to gene editing have gained more than 25% since its early February initial public offering.

Beam Therapeutics Inc.'s (BEAM) stock traded near $32 just days after it went public at an offering price of $17, but has since receded to $21.49. At its current price, many think the company is a bargain.

Among the optimists are the analysts at several firms that underwrote the offering, reported 24/7 Wall Street. Of course, it’s little surprise that they have a buy or outperform rating for the stock.

Jefferies started

216 Views    Barry Cohen    2020-05-18 21:21

Headlines Total 20
  • 1

2020-05-26 $ 24.32 (-5.07%)
7:01am
2020-05-18 $ 21.49 (0.37%)
4:21pm
2020-05-12 $ 19.95 (-3.67%)
7:02am
2020-04-29 $ 16.3 (-1.39%)
7:01pm
7:00pm
2020-03-30 $ 18 (-0.28%)
7:00am
2020-03-16 $ 13.31 (-23.42%)
7:00am
2015-01-30
4:00pm
2014-06-09
11:57am
2014-04-30
1:55pm
2014-04-18
4:36pm
2014-03-11
10:42am
2014-01-21
9:28am
2014-01-13
1:11pm
2013-05-30
10:06am
2013-04-06
4:33pm
2012-11-06
4:47pm
2012-05-04
9:29am
2012-01-25
5:30pm
8:51am
Total 20
  • 1